Recombinant Methanocaldococcus jannaschii UPF0252 protein MJECL39 (MJECL39)

Shipped with Ice Packs
In Stock

Description

Introduction to MJECL39

Recombinant Methanocaldococcus jannaschii UPF0252 protein MJECL39 (Uniprot ID: Q60294) is a synthetic protein derived from the hyperthermophilic archaeon Methanocaldococcus jannaschii. This organism, renowned for its thermophilic methanogenesis, has been a model system for studying extremophile biochemistry. The UPF0252 family represents uncharacterized proteins of unknown function (UPFs) across diverse microbial genomes. MJECL39 is produced via recombinant DNA technology, typically expressed in heterologous systems like E. coli for structural or functional studies .

Research Applications and Functional Insights

While MJECL39’s biological role remains uncharacterized, its recombinant production enables investigations into:

Comparative Genomics and UPF Families

  • UPF0252 Orthologs: Proteins in the UPF0252 family are conserved across archaea, bacteria, and eukaryotes, hinting at an ancient evolutionary origin. Functional studies in M. jannaschii could provide insights into conserved biochemical processes .

  • Distant Homologs: Phylogenetic analyses may link MJECL39 to uncharacterized enzymes or structural proteins, though no direct homologs with known functions (e.g., methyltransferases, hydrogenases) are reported in M. jannaschii .

Limitations and Future Directions

ChallengeImplications
Lack of Functional DataNo direct studies link MJECL39 to specific biochemical pathways or enzymatic activities.
Recombinant ExpressionHeterologous systems may not replicate native folding or cofactor binding.
Research AvailabilityLimited to commercial suppliers; no peer-reviewed studies explicitly use MJECL39.

Critical Research Gaps:

  1. Enzymatic Activity: Screens for catalytic functions (e.g., methyltransferase, hydrolase) remain unexplored.

  2. Interactome Mapping: Potential interactions with other M. jannaschii proteins (e.g., FprA, Trm14) are unstudied .

  3. Structural Characterization: X-ray crystallography or cryo-EM studies could elucidate its tertiary structure.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
MJECL39; UPF0252 protein MJECL39
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-351
Protein Length
full length protein
Species
Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii)
Target Names
MJECL39
Target Protein Sequence
MPILLEHIQLNDEDLKDTKHLAEILKYKNNSIKTIINVLEWEDSNIRYCYEKSNVYYFIT FFIIVGLVWAIFPEVWLWCEQVFCISPTIHIIICCLYFIITIILFLFLCGVVGTFLHLWA TFFTLSKCDSKILKLKEGLFTTLSLIWISTSLKTILKTKYAICRDYAKLTSAILHNLNIK HYFLVYPTHVAVAVKIDDYYYVIDQKLPIYKIDVWLKKLGKEKVKIYTPVDIYNSKLKFV EKYYKNENNLKSEISDDILRKIEEDVKKELQIKNAEQYNKKVEPIPVKLSIPIENYDEIT HYSIVRVISKEIYNKFLTNIKNVSNIEIKKDEGKFAVNVYYEIPNSIPNSK
Uniprot No.

Target Background

Database Links

KEGG: mja:MJ_ECL39

Protein Families
UPF0252 family
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is Methanocaldococcus jannaschii and why is it significant for protein studies?

Methanocaldococcus jannaschii is a hyperthermophilic methanogenic archaeon that was originally isolated from deep-sea hydrothermal vents. This organism is phylogenetically deeply rooted in the tree of life and is considered an evolutionary significant methanarchaeon . M. jannaschii grows optimally at temperatures around 85°C under strictly anaerobic conditions, making it an extremophile of considerable interest to biochemists and structural biologists.

The significance of M. jannaschii for protein studies stems from its adaptation to extreme environments. Its proteins possess remarkable thermostability and often contain unique structural features that allow function under conditions that would denature most mesophilic proteins. The UPF0252 protein family, to which MJECL39 belongs, represents one of many uncharacterized protein families in this organism that may harbor novel functions adapted to extreme conditions.

What genetic tools are available for studying proteins in M. jannaschii?

Several genetic tools have been developed specifically for M. jannaschii that enable sophisticated molecular biology approaches:

  • Selectable marker system: A M. jannaschii-specific selectable marker composed of the HMG-CoA reductase gene (hmgA, mj_0705) driven by the S-layer gene promoter (Psla) from Methanocaldococcus FS.406-22. This marker confers resistance to mevinolin and simvastatin .

  • Suicide plasmids: Plasmids like pDS210 allow for chromosomal deletion through homologous recombination. These contain sequences flanking target genes to facilitate double crossover events .

  • Protein expression systems: High-level expression cassettes utilizing promoters such as the flagellin operon promoter (PflaB1B2) enable efficient protein production .

  • Affinity tag systems: The successful implementation of the 3xFLAG-Twin Strep tag system has been demonstrated, allowing for tandem affinity purification of M. jannaschii proteins .

These tools collectively allow researchers to manipulate the M. jannaschii genome to delete genes, overexpress proteins with affinity tags, and perform detailed functional analyses of proteins like MJECL39.

What is known about the UPF0252 protein family?

The UPF0252 protein family belongs to the group of uncharacterized protein families (UPF), which are proteins that have been identified through genomic sequencing but whose functions remain unknown or poorly understood. While specific information about MJECL39 is limited in the current literature, analysis of this protein family typically involves:

  • Sequence analysis: Identifying conserved domains and motifs that might suggest function.

  • Structural predictions: Utilizing tools like AlphaFold to predict tertiary structure based on primary sequence.

  • Genomic context: Examining neighboring genes that may be functionally related, as many archaeal genes are organized in operons with related functions.

For characterization of similar proteins, researchers have employed expression systems like those described for FprA in M. jannaschii, which successfully maintained native activity of the expressed protein .

What expression systems are most effective for recombinant M. jannaschii proteins?

Based on experimental evidence, several expression systems have proven effective for M. jannaschii proteins, with the choice depending on research goals:

Homologous Expression in M. jannaschii:
The most authentic approach involves expressing the protein in M. jannaschii itself. A system utilizing the flagellin operon promoter (PflaB1B2) coupled with a 3xFLAG-Twin Strep affinity tag has been successfully demonstrated for the FprA protein, yielding 0.26 mg of purified protein per liter of culture . This approach is particularly valuable for proteins requiring:

  • M. jannaschii-specific prosthetic groups or cofactors

  • Specific types of posttranslational modifications

  • Folding assistance by M. jannaschii chaperones

Table 1: Comparison of Expression Systems for M. jannaschii Proteins

Expression SystemAdvantagesLimitationsYieldBest For
M. jannaschii (homologous)Native folding, authentic PTMs, correct cofactor incorporationTechnical complexity, lower yields~0.26 mg/LProteins requiring native cofactors or PTMs
E. coli (heterologous)Higher yields, easier manipulationMay lack proper folding or modificationsVariableProteins without special requirements
Other thermophilesBetter folding than mesophilic hostsLess established protocolsVariableAlternative when M. jannaschii expression fails

What affinity tags are recommended for purification of M. jannaschii recombinant proteins?

The 3xFLAG-Twin Strep affinity tag system has been demonstrated to be particularly effective for M. jannaschii protein purification. This dual-tag approach provides several advantages:

  • High specificity: Both FLAG and Strep tags offer exceptionally specific binding to their respective resins, minimizing non-specific contamination.

  • Tandem affinity purification capability: This approach allows for the isolation of protein complexes with reduced co-purification of functionally unrelated proteins .

  • Verified functionality in M. jannaschii: The system has been proven to work in the native organism without compromising protein activity. For example, tagged FprA retained high enzymatic activity (2,100 μmole/min/mg at 70°C) .

  • Detection capabilities: The FLAG tag enables easy detection via Western blotting using commercially available antibodies .

The purification protocol typically involves using a Streptactin XT superflow column with elution using 10 mM D-biotin. This approach has yielded highly purified protein as confirmed by SDS-PAGE analysis and mass spectrometry .

How should appropriate sample sizes be calculated for experiments with M. jannaschii proteins?

Although not specific to M. jannaschii proteins, sound experimental design principles dictate that researchers should:

  • Conduct an a priori power analysis to determine the minimum sample size needed:

    • Define alpha (typically 0.05)

    • Determine desired power (typically 0.8 or higher)

    • Estimate expected effect size based on preliminary data or related studies

    • Calculate the minimum required sample size based on these parameters

  • Implement a minimum of n = 5 independent samples per experimental group for any data subjected to statistical analysis .

  • If working with smaller sample sizes (n < 5), provide a valid scientific justification in the methods section, but note that such small groups should not be subjected to statistical analysis due to unreliable P values .

  • When designing experiments to characterize recombinant proteins like MJECL39, consider both technical replicates (multiple measurements from the same sample) and biological replicates (independent protein preparations).

Following these guidelines ensures that experiments are adequately powered to detect meaningful effects while maintaining scientific rigor.

What statistical approaches are appropriate for analyzing protein characterization data?

For the rigorous analysis of protein characterization data, particularly for thermostable proteins like those from M. jannaschii, appropriate statistical approaches include:

  • For enzyme kinetic data (as seen with transaldolase from M. jannaschii):

    • Non-linear regression for determining kinetic parameters (Km, Vmax)

    • Report both best-fit values and confidence intervals

    • Select enzyme kinetic models based on observed data patterns

The transaldolase from M. jannaschii demonstrates that kinetic parameters should be determined at multiple temperatures, as Vmax = 1.0 ± 0.2 μmol min⁻¹ mg⁻¹ at 25°C, while Vmax = 12.0 ± 0.5 μmol min⁻¹ mg⁻¹ at 50°C, representing a 12-fold difference .

  • For comparative studies:

    • Use parametric tests only when data meet assumptions of normality and equal variance

    • Apply appropriate corrections for multiple comparisons

    • Maintain minimum sample sizes (n=5) for statistical analysis

    • Report exact P values rather than threshold statements

  • For reporting:

    • Present data in tables with clear statistical parameters

    • Include both graphical representation and statistical analysis

    • Document statistical tests used in the methods section

How does the extreme thermophilic nature of M. jannaschii affect protein folding and stability studies?

The extreme thermophilic nature of M. jannaschii, which grows optimally around 85°C, profoundly impacts protein folding and stability studies:

  • Extraordinary thermostability: M. jannaschii proteins demonstrate remarkable stability at high temperatures. For instance, the transaldolase enzyme retained full activity for 4 hours at 80°C and remained stable for 3 weeks at 25°C .

  • Temperature-dependent activity: Activity measurements at standard laboratory temperatures often underestimate the true enzymatic potential of M. jannaschii proteins. The transaldolase exhibited a 12-fold increase in activity when measured at 50°C compared to 25°C .

  • Substrate affinity variations: The apparent Michaelis constants also vary with temperature and substrate. For the transaldolase, Km = 0.65 ± 0.09 mM for fructose-6-phosphate and Km = 27.8 ± 4.3 μM for erythrose-4-phosphate at 50°C .

  • Experimental design implications:

    • Denaturation studies must be conducted at much higher temperatures than for mesophilic proteins

    • Activity assays should be performed across a range of temperatures to determine temperature optima

    • Stability assays should include extended time points to capture the remarkable longevity of these proteins

These considerations are crucial when working with MJECL39, as conventional protocols may need significant modification to accommodate its likely extreme thermostability.

What strategies can overcome challenges in expressing hyperthermophilic proteins in mesophilic hosts?

Expressing hyperthermophilic proteins from M. jannaschii in mesophilic hosts presents specific challenges that can be addressed through several strategies:

  • Codon optimization: Adapting the coding sequence to the codon usage bias of the expression host can improve translation efficiency.

  • Chaperone co-expression: M. jannaschii proteins may "require folding by a chaperone from this organism for exhibiting the native activity" . Co-expressing archaeal chaperones in the mesophilic host can facilitate proper folding.

  • Temperature modulation: Lowering the expression temperature can slow protein synthesis and folding, potentially allowing more time for proper folding.

  • Fusion partners: Solubility-enhancing fusion tags can improve folding and solubility of recombinant hyperthermophilic proteins.

  • Cofactor supplementation: Some M. jannaschii proteins require "specific prosthetic groups or cofactors" . Supplementing the growth medium with appropriate cofactors may be necessary.

  • Alternative expression hosts: When all else fails, homologous expression in M. jannaschii itself may be the only viable option, as demonstrated for FprA .

How can post-translational modifications be identified in recombinant MJECL39?

To identify post-translational modifications (PTMs) in recombinant MJECL39, a systematic analytical approach should be employed:

  • Mass spectrometry analysis:

    • Intact protein mass spectrometry to detect mass differences compared to the theoretical value

    • Peptide mass fingerprinting following proteolytic digestion

    • Tandem mass spectrometry (MS/MS) for detailed mapping of modification sites

This approach was successfully used for FprA, where "mass spectrometric analysis with a thermolysin digest identified 41 peptides that belonged to Mj-FprA and accounted for 55% of the primary structure of the protein" .

  • Comparative analysis:

    • Comparison of proteins expressed in different systems (e.g., E. coli vs. M. jannaschii homologous expression)

    • Analysis before and after treatment with specific demodifying enzymes

  • Functional impacts assessment:

    • Determine whether potential modifications affect protein activity or stability

    • Correlate the presence or absence of modifications with functional outcomes

Search result highlights that homologous expression would be valuable for proteins that "undergo specific types of posttranslational modifications" in M. jannaschii, suggesting that certain PTMs may not be properly added in heterologous systems.

Why might recombinant MJECL39 show different properties compared to the native protein?

Recombinant MJECL39 might exhibit different properties compared to the native protein for several reasons:

  • Expression system differences: Heterologous expression may lack "M. jannaschii-specific prosthetic groups or cofactors, specific types of posttranslational modifications, or folding by a chaperone from this organism" .

  • Temperature effects on folding: Proteins from hyperthermophiles like M. jannaschii have evolved to fold correctly at high temperatures. Expression at lower temperatures may result in misfolding.

  • Affinity tag influences: While the 3xFLAG-Twin Strep tag has been successfully used for FprA without compromising activity , tags may affect some proteins differently.

  • Absence of native cofactors: Many archaeal proteins require specific cofactors for activity. FprA, for example, utilizes coenzyme F420 as a key cofactor for its activity .

  • Post-translational modifications: Archaeal proteins often undergo unique post-translational modifications that may not be replicated in heterologous systems.

  • Experimental conditions: Activity measurements must be conducted under conditions that mimic the native environment. For instance, the transaldolase from M. jannaschii showed 12-fold higher activity at 50°C compared to 25°C .

Understanding these factors is crucial for properly interpreting experimental results and developing strategies to produce recombinant protein with properties closely resembling the native form.

How can contradictory results in activity assays for MJECL39 be resolved?

Resolving contradictory results in activity assays for MJECL39 requires a systematic troubleshooting approach:

  • Temperature optimization:

    • Conduct assays across a range of temperatures (25-85°C)

    • Create an activity vs. temperature profile to identify the optimal temperature

    • Remember that M. jannaschii enzymes can show dramatically different activities at different temperatures, as demonstrated by the 12-fold higher activity of transaldolase at 50°C vs. 25°C

  • Buffer and assay condition optimization:

    • Systematically vary pH, salt concentration, and buffer composition

    • Test for cofactor requirements, as seen with the F420H2 requirement for FprA activity

  • Substrate specificity assessment:

    • Test multiple potential substrates

    • Similar to how MJ0960 was shown to have transaldolase activity but not fructose-6-phosphate aldolase activity

    • Vary substrate concentrations to generate reliable kinetic parameters

  • Protein quality assessment:

    • Verify protein folding using biophysical techniques

    • Check for protein aggregation

    • Assess the impact of affinity tags on activity

  • Expression system comparison:

    • Compare protein expressed in different systems, particularly between heterologous systems and homologous expression in M. jannaschii

  • Rigorous statistical analysis:

    • Ensure adequate sample sizes (minimum n=5)

    • Use appropriate statistical tests

    • Report exact P values and measures of variability

By systematically addressing these factors, contradictory results can often be resolved and a clear understanding of MJECL39's activity profile established.

What controls are essential when characterizing an uncharacterized protein like MJECL39?

When characterizing an uncharacterized protein like MJECL39, implementing appropriate controls is crucial for generating reliable results:

  • Expression system controls:

    • Empty vector control: Express and purify from the same system without the MJECL39 gene

    • Known protein control: Express a well-characterized protein using the same system

    • Wild-type M. jannaschii strain as a baseline control if using homologous expression

  • Protein quality controls:

    • Denatured protein control: Deliberately denature a portion of purified protein

    • Protein stability time course: Monitor activity over time under storage conditions

    • Mass spectrometry confirmation of protein identity, similar to the approach used for FprA where "mass spectrometric analysis with a thermolysin digest identified 41 peptides"

  • Activity assay controls:

    • No-enzyme controls: Perform assays with all components except the protein

    • Substrate specificity controls: Test structurally related non-substrate molecules

    • Temperature controls: Test at multiple temperatures, given the dramatic temperature-dependence of M. jannaschii enzyme activities

  • Experimental design controls:

    • Buffer composition controls: Systematically vary pH, salt, and cofactors

    • Implement appropriate sample sizes (minimum n=5 for statistical analysis)

    • Include both technical replicates (multiple measurements from same preparation) and biological replicates (independent protein preparations)

  • Structural analysis controls:

    • Compare structural parameters with well-characterized proteins from the same family

Following these control practices will help distinguish true results from artifacts and provide a robust framework for characterizing MJECL39.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.